van den Brink W - Search Results

1

van Amsterdam J, Nutt D, Phillips L, van den Brink W. van Amsterdam J, et al. Among authors: van den brink w. J Psychopharmacol. 2015 Jun;29(6):655-60. doi: 10.1177/0269881115581980. Epub 2015 Apr 28. J Psychopharmacol. 2015. PMID: 25922421

2

Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study.

de Win MM, Schilt T, Reneman L, Vervaeke H, Jager G, Dijkink S, Booij J, van den Brink W. de Win MM, et al. Among authors: van den brink w. J Psychopharmacol. 2006 Mar;20(2):226-35. doi: 10.1177/0269881106063275. J Psychopharmacol. 2006. PMID: 16510480

3

Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population.

van Amsterdam J, Opperhuizen A, Koeter M, van den Brink W. van Amsterdam J, et al. Among authors: van den brink w. Eur Addict Res. 2010;16(4):202-7. doi: 10.1159/000317249. Epub 2010 Jul 2. Eur Addict Res. 2010. PMID: 20606445

4

Instability of the ecstasy market and a new kid on the block: mephedrone.

Brunt TM, Poortman A, Niesink RJ, van den Brink W. Brunt TM, et al. Among authors: van den brink w. J Psychopharmacol. 2011 Nov;25(11):1543-7. doi: 10.1177/0269881110378370. Epub 2010 Sep 8. J Psychopharmacol. 2011. PMID: 20826554

5

Ranking of drugs: a more balanced risk-assessment.

van Amsterdam J, van den Brink W. van Amsterdam J, et al. Among authors: van den brink w. Lancet. 2010 Nov 6;376(9752):1524-5. doi: 10.1016/S0140-6736(10)62000-4. Epub 2010 Oct 29. Lancet. 2010. PMID: 21036391 No abstract available.

6

Harm potential of magic mushroom use: a review.

van Amsterdam J, Opperhuizen A, van den Brink W. van Amsterdam J, et al. Among authors: van den brink w. Regul Toxicol Pharmacol. 2011 Apr;59(3):423-9. doi: 10.1016/j.yrtph.2011.01.006. Epub 2011 Jan 21. Regul Toxicol Pharmacol. 2011. PMID: 21256914 Review.

7

Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands.

van Amsterdam JG, van Laar M, Brunt TM, van den Brink W. van Amsterdam JG, et al. Among authors: van laar m, van den brink w. Regul Toxicol Pharmacol. 2012 Jun;63(1):55-63. doi: 10.1016/j.yrtph.2012.03.005. Epub 2012 Mar 14. Regul Toxicol Pharmacol. 2012. PMID: 22440552

8

Efficacy of contingency management for cocaine dependence treatment: a review of the evidence.

Schierenberg A, van Amsterdam J, van den Brink W, Goudriaan AE. Schierenberg A, et al. Among authors: van den brink w, van amsterdam j. Curr Drug Abuse Rev. 2012 Dec;5(4):320-31. doi: 10.2174/1874473711205040006. Curr Drug Abuse Rev. 2012. PMID: 23244344 Review.

9

[Cognitive impairment due to intensive use and overdoses of gammahydroxybutyric acid (GHB)].

van Amsterdam JG, Brunt TM, McMaster MT, Niesink R, van Noorden MS, van den Brink W. van Amsterdam JG, et al. Among authors: van den brink w, van noorden ms. Tijdschr Psychiatr. 2012;54(12):1001-10. Tijdschr Psychiatr. 2012. PMID: 23250641 Free article. Review. Dutch.

10

The high harm score of alcohol. Time for drug policy to be revisited?

van Amsterdam J, van den Brink W. van Amsterdam J, et al. Among authors: van den brink w. J Psychopharmacol. 2013 Mar;27(3):248-55. doi: 10.1177/0269881112472559. Epub 2013 Jan 16. J Psychopharmacol. 2013. PMID: 23325370 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

715 results

Search Page

Filters